Correction: Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma

Affiliations

¹ Department of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel.
² Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea.
³ Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
⁴ NUS-HUJ-CREATE Cellular & Molecular Mechanisms of Inflammation Program, Department of Microbiology and Immunology, National University of Singapore, Singapore.
⁵ Department of Pathology, Seoul National University Hospital, Seoul, Korea.
⁶ Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Korea.
⁷ Kaplan Medical Center, Rehovot, Israel.
⁸ Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel.

^# Contributed equally.

Published Erratum

Suliman Boulos et al. Oncotarget. 2018.

. 2018 Nov 16;9(90):36250.

doi: 10.18632/oncotarget.26387.

¹ Department of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel.
² Medicinal Bioconvergence Research Center, Seoul National University, Seoul, Korea.
³ Department of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, The Hebrew University of Jerusalem, Jerusalem, Israel.
⁴ NUS-HUJ-CREATE Cellular & Molecular Mechanisms of Inflammation Program, Department of Microbiology and Immunology, National University of Singapore, Singapore.
⁵ Department of Pathology, Seoul National University Hospital, Seoul, Korea.
⁶ Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul, Korea.
⁷ Kaplan Medical Center, Rehovot, Israel.
⁸ Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.18632/oncotarget.18053.].

Serine 207 phosphorylated lysyl-tRNA synthetase predicts disease-free survival of non-small-cell lung carcinoma.
Boulos S, Park MC, Zeibak M, Foo SY, Jeon YK, Kim YT, Motzik A, Tshori S, Hamburger T, Kim S, Nechushtan H, Razin E. Boulos S, et al. Oncotarget. 2017 May 22;8(39):65186-65198. doi: 10.18632/oncotarget.18053. eCollection 2017 Sep 12. Oncotarget. 2017. PMID: 29029422 Free PMC article.